Steroids during acute COVID-19 do not prevent long COVID in children, large RECOVER study finds
By
Kathryn Hirabayashi,
Summary
This study from the RECOVER Initiative evaluated whether steroid use (dexamethasone, prednisone, prednisolone, methylprednisolone) during acute SARS-CoV-2 infection prevents long COVID in children. Using a retrospective cohort design with target trial emulation methodology, researchers analyzed 854,128 children/youth (768,845 outpatients and 85,283 inpatients). After propensity weighting, the study found that steroids did not reduce the overall risk of post-acute sequelae of SARS-CoV-2 (PASC) in either hospitalized or outpatient children, with one exception: a lower risk of gastrointestinal PASC in hospitalized treated patients (HR: 0.58; 95% CI: 0.39–0.85, p = 0.01). The authors conclude that additional studies are needed to confirm the benefit of steroids and other immunomodulators in preventing long COVID in children.
Source
Key quotes
· 4 pulledIn hospitalized patients, there were no significant treatment differences in the development of PASC in the 1−6 months following acute SARS-CoV-2 infection except for a lower risk of gastrointestinal PASC in treated patients (HR: 0.58; [95% CI: 0.39–0.85], p = 0.01).
In outpatients, no treatment differences were observed in the development of PASC subphenotypes.
Steroids administered during acute SARS-CoV-2 infection did not lead to a decreased risk of PASC, with the exception of gastrointestinal presentations.
Additional studies are needed to confirm the benefit of steroids and other immunomodulators in preventing long COVID.
You might also wanna read
Study: Metformin During Acute COVID Shows Mixed Results for Preventing Long COVID
A study led by Carolyn T. Bramante at the University of Minnesota found that a 14-day course of metformin during acute COVID-19 did not defi
Microfluidic Assay Quantifies Fibrinaloid Clots in Pediatric Long COVID Patients
This research article presents a study using microfluidic assays to quantify fibrinaloid clots in plasma from pediatric Long COVID patients.
Long Covid is a stable, maladaptive immunometabolic state, not just random leftover damage, and it has big implications for how we design biomarkers and treatments.

Study Examines Association Between mRNA COVID-19 Vaccination and 4-Year All-Cause Mortality in French Adults Aged 18-59
This cohort study analyzes data from over 28 million French adults aged 18-59 to examine the association between mRNA COVID-19 vaccination a

Emerging Evidence Challenges Immunity Debt Theory, Suggests SARS-CoV-2 Alters Immune Systems
Scientists are challenging the 'immunity debt' theory that explained post-pandemic infection surges, instead proposing that SARS-CoV-2 may b

Study links Long COVID neurological symptoms to immune system attacking nervous system
Researchers have found evidence that some Long COVID patients experience neurological symptoms because their immune system produces antibodi

Comments
Sign in to join the conversation.
No comments yet. Be the first.